Launch of the Canada-Japan CEEHRC Teams in Epigenetics of Stem Cells

The Canadian Institutes of Health Research (CIHR) and the Japan Science and Technology Agency (JST) will be launching over the next few days an exciting new funding opportunity called Canada-Japan CEEHRC Teams in Epigenetics of Stem Cells. This agreement was established under CIHR's Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC), one of CIHR's Roadmap Signature Initiatives, and JST's Strategic International Collaborative Research Program (SICORP).

Dr. Alain Beaudet, CIHR's President (left) and Dr. Michiharu Nakamura, JST's President (right) signing the partnership agreement.

Through this funding opportunity, CIHR and JST are interested in supporting multi-national research Teams in the area of the epigenetics of stem cells. As considerable scientific expertise in stem cell research exists in both Japan and Canada. The aim of this joint program is to strengthen collaborations between Japan and Canada to potentially address some of the major technological hurdles in advancing stem cell research. It is expected that these joint research programs could lead to new innovative technologies and approaches in the area of health research in both countries.

These larger goals of the Canada-Japan collaboration are consistent with the CEEHRC Team Grant funding opportunity, which aims to link innovative research in epigenetics to human health and disease. Toward this end, CEEHRC recognizes the importance of all levels of research in epigenetics, from individual cells to whole populations. Key to all approaches is a focus on collaborative research – namely, integrating different methodologies and disciplines aligned along key health needs. It is expected that the combined investment of the Canada-Japan program will increase capacity in both countries for high-quality research on relevant diseases, the health of populations, and health care and health system issues.

The specific objective of this funding opportunity is to achieve high impact scientific results in the epigenetics of stem cells. This includes the transcriptional control of differentiation and the induction of pluripotency. This research may lead to new innovative technologies which could address major challenges in the basic understanding of stem cell activity and function, as well as remove barriers to effective translation of stem cell research for health benefits.

Under the partnership, CIHR has committed up to $6M CAD and JST 600M Yen (approximately $8M CAD) for a total investment of $14M CAD over the next five years. The funding will support a maximum of three research teams that will require the participation of Canadian and Japanese researchers.

Please note that JST's Strategic International Collaborative Research Program (SICORP) application guide for Japanese researchers is now available on JST's eRad system and can also be found on JST's homepage.

To view the Canada-Japan CEEHRC Teams in Epigenetics of Stem Cells funding opportunity please visit CIHR's Funding website over the next few days.

For further details please contact:

For Canada-based applicants: 

For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

Bryan Lemire
Program Delivery Coordinator, CIHR
Telephone: 613-941-1298
Fax: 613-954-1800
Email: bryan.lemire@cihr-irsc.gc.ca

For questions about this initiative and research objectives contact:

Dr. Eric Marcotte
Associate Director, Regenerative Medicine and Nanomedicine Initiative, CIHR
Telephone: 905-467-1822
Email: eric.marcotte@cihr-irsc.gc.ca

For Japan-based applicants:

For questions on JST funding guidelines, how to apply, and the peer review process contact:

Dr. Hideo Nakajima
Deputy Manager, Department of International Affairs

Ms. Kyoko Tsukamoto
Staff, Department of International Agency
Email: jointca@jst.go.jp

Date modified: